The Hypertension project (HTN) is a digital health service that brings hypertension management to the people’s homes. The approach is patient centered and scalable. We believe this will result in better health at lower costs. Ahti works on the HTN project together with an international consortium.
Cardiovascular disease (CVD) is the number one cause of death globally. The leading cause of CVD is elevated blood pressure or hypertension (HTN). Worldwide there are at least 1,1 billion people who suffer from HTN. Globally, only around 13% of people with hypertension have their blood pressure at target. Low and middle income countries account for over 80% of global CVD deaths.
The current model of clinic based care is ineffective and too costly to sustain. Even in high income countries, there are not enough doctors for the increasing number of people who need hypertension care. Despite the fact that behavioral changes and drug treatment can greatly reduce the risk of CVD, HTN control is still poor. There is an urgent need for cheaper and more effective solutions that allow rapid scale up of hypertension care to reach everybody in need.
The purpose of the project
The aim of the project is to develop and test a health service for measuring and monitoring hypertension that will be home based instead of clinic based. We do this by using a mobile phone app for patients that interacts with a web based dashboard for healthcare providers that can act and change treatment if needed.
Since behavior is a major driver of health outcomes in chronic conditions, behavioral psychologists have been involved in co-designing the model. As a result, expensive, clinic based care will completely transform into a more efficient, home based, patient centered way of working.
What is ahti’s role
Ahti initiated the project and brought together world renowned clinical and behavioral research experts within its global network of Living Labs. This network provides direct access to patient populations, local municipal health departments, policy makers and payer data, so that new technology can be tested in a real world setting – both in high as well as in middle and low income countries.
Name: Hypertension project
Countries: China, Kenya, the Netherlands, USA
- Academic/ clinical: AIGHD, Duke Primary Care, African Population Health and Research Centre (Nairobi), Duke Kunshan University, Chongqing Medical University
- Implementation: PharmAccess International
- Private: M2mobi Mobile Agency
- Clinical: Primary care facilities in all four countries
Funded by: ahti, JLI, DKU, Chongqing Medical university, Zilveren Kruis
For more information: Mark Geels, Senior Program Manager